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Summary 
Impaired heart rate variability (HRV) is associated with increased risk of 
cardiovascular disease, but evidence regarding alterations of HRV in metabolic 
syndrome (MetS) remains elusive. In order to examine HRV in MetS, we subjected 
501 volunteers without atherosclerosis, diabetes, or antihypertensive medication, 
mean age 48 years, to passive head-up tilt. The subjects were divided to control men 
(n=131), men with MetS (n=121), control women (n=191), and women with MetS 
(n=58) according to the criteria by Alberti et al. 2009. In unadjusted analyses 1) men 
and women with MetS had lower total power and high frequency (HF) power of HRV 
than controls whether supine or upright (p<0.05 for all). 2) Supine low frequency (LF) 
power of HRV was lower in men (p=0.012) but not in women (p=0.064) with MetS 
than in controls, while men and women with MetS had lower upright LF power of 
HRV than controls (p<0.01 for both). 3) The LF:HF ratio did not differ between 
subjects with and without MetS. After adjustment for age, smoking habits, alcohol 
intake, height, heart rate, and breathing frequency, only the differences in upright 
total power and HF power of HRV between women with MetS and control women 
remained significant (p<0.05). In conclusion, reduced total and HF power of HRV in 
the upright position may partially explain why the relative increase in cardiovascular 
risk associated with MetS is greater in women than in men. Additionally, the present 
results emphasize that the confounding factors must be carefully taken into 
consideration when evaluating HRV. 
 
Keywords: cardiac autonomic tone, heart rate variability, head-up tilt, sex, 
cardiovascular risk 
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Introduction 
 
Metabolic syndrome (MetS), a disorder characterized by a cluster of unfavourable 
changes in lipid profile, blood pressure, glucose metabolism, and waist 
circumference is very common, especially in the Western countries. MetS is related 
to an increased risk of diabetes and cardiovascular disease (CVD) (Alberti et al., 
2009), while CVDs are the most important factor causing mortality worldwide (Mendis 
S, 2011). Consequently, MetS has been under active investigation during the last 
decades. However, the mechanisms linking MetS with increased risk of CVD are still 
incompletely understood (Mottillo et al., 2010). 
Imbalance in the autonomic nervous system with sympathetic overdrive has been 
linked with MetS (Grassi, 2006). An applicable, non-invasive method for the 
evaluation of cardiac autonomic tone is the measurement of heart rate variability 
(HRV). Decreased vagal activity, as indicated by HRV, has been shown to predict 
mortality in both high risk and low risk populations (Thayer et al., 2010; Wulsin et al., 
2015). According to a recent systematic review (Stuckey et al., 2014), numerous 
cross-sectional studies have revealed impaired cardiac autonomic function 
associated with MetS. Furthermore, a longitudinal study showed that low HRV 
increased the odds of developing MetS during 12 years of follow-up (Wulsin et al., 
2016).  
In previous studies, MetS was associated with lower indices of HRV, but the results 
have not been consistent (Stuckey et al., 2014). In many reports, the changes of 
cardiac autonomic tone in MetS seemed to be more pronounced in women than in 
men (Koskinen et al., 2009; Stuckey et al., 2014; Stuckey et al., 2015). Several 
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studies suggested that the association of MetS with cardiovascular end-points is also 
stronger in women than in men (Hunt et al., 2004; Schillaci et al., 2006). This raises 
the question whether the sex-related differences in autonomic tone in MetS could 
play a role to explain these differences. 
In addition to various medical conditions, also age (Bonnemeier et al., 2003), sex 
(Koenig & Thayer, 2016), heart rate (HR) (Billman, 2013a; Sacha, 2014), circadian 
rhythm (Bonnemeier et al., 2003), and breathing frequency (Stolarz et al., 2003; 
Billman, 2011) can influence HRV. In many studies evaluating HRV in MetS these 
factors were somewhat neglected, and this may explain some of the discrepancies in 
the published results (Stuckey et al., 2014). According to a review published in 2014 
(Stuckey et al., 2014), only three reports had separated the analyses by sex, while 
only one study in young adults had adjusted the HRV results for HR (Koskinen et al., 
2009), although increased HR is characteristic of subjects with MetS (Mancia et al., 
2007). To our knowledge, no HR adjusted results of HRV in MetS have been 
published thereafter. 
Importantly, many antihypertensive medications like beta-blockers (Vaile et al., 
1999), calcium channel blockers (Karas et al., 2005), angiotensin receptor blockers 
(Karas et al., 2005; Okano et al., 2009) and angiotensin-converting enzyme inhibitors 
(Karas et al., 2005) can influence HRV. Hypertension is very common in MetS, and in 
many studies evaluating HRV in MetS, subjects with antihypertensive medication 
were included (Stuckey et al., 2014), and this has probably also contributed the 
discrepancy in the published results. 
In the current study, we examined changes in HRV associated with MetS separately 
in men and women. None of the subjects used antihypertensive agents or other 
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medications with direct cardiovascular influences, and the differences of HR and 
breathing frequency were also taken into account. As upright position is 
characterised by differences in the haemodynamic responses between men and 
women (Kangas et al., 2016), we examined HRV during supine and upright positions. 
 
Methods 
Study subjects 
This study is part of an ongoing investigation of haemodynamics in the University of 
Tampere (DYNAMIC-study, ClinicalTrials.gov identifier NCT01742702). The 
recruiting of participants and the data collection have been previously described 
(Kangas et al., 2016). The population of the current study was screened from 1091 
subjects. The exclusion criteria were diagnosed atherosclerosis, cardiac insufficiency 
or cerebrovascular disease, diabetes, and use of antihypertensive drugs or other 
medications having influences on haemodynamics (like β-blocker eye drops for 
glaucoma, β2-adrenoceptor agonists, α1-adrenoceptor blockers for prostate 
problems, and digoxin). After the exclusion process, 501 subjects aged 19-72 years 
were eligible for the study population. Clinical cardiovascular status was examined, 
lifestyle habits, medical history, family history, and use of medicines were recorded, 
and laboratory tests were taken before the haemodynamic recordings. 
For the definition of MetS, the criteria of Alberti et al. from 2009 (Alberti et al., 2009) 
were used, so that three or more of the following criteria were met: waist 
circumference ≥ 94 cm (men) and ≥ 80 cm (women); high density lipoprotein 
cholesterol (HDL-C)  <1.0 mmol/l (men) and <1.3 mmol/l (women); triglycerides ≥ 1.7 
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mmol/l; fasting plasma glucose ≥ 5.6 mmol/l; systolic BP ≥ 130 mmHg and/or 
diastolic BP ≥ 85 mmHg. The study subjects were allocated to 4 groups: men without 
MetS (M-control, n=131), men with MetS (M-MetS, n=121), women without MetS 
(W-control, n=191), and women with MetS (W-MetS, n=58). 
Although none of the subjects used antihypertensive agents, medications not 
affecting haemodynamics were allowed. Altogether 186 subjects (37%) used some 
medication. Thirteen had statins for dyslipidemia, 77 female participants (31%) used 
systemic female hormones (hormone replacement therapy or contraception). In the 
use of female hormones, no difference was found between W-control and W-MetS 
groups (p=0.761). Additionally, some other drugs (e.g. antihistamines, thyroid 
hormones, proton pump inhibitors, acetylsalicylic acid, selective serotonin re-uptake 
inhibitors, and intranasal or inhaled corticosteroids) were used by the participants. 
One subject had anti-phospholipid syndrome without any symptoms or findings, and 
he was receiving warfarin.  
 
Measuring heart rate variability during passive head up tilt test 
The participants were instructed to refrain from smoking, caffeine containing products 
and heavy meals for ≥ 4 hours, and from alcohol for ≥ 24 hours prior to the 
recordings. The recordings were performed in a temperature-controlled laboratory by 
a trained research nurse during two consecutive 5-minute periods with continuous 
capture of data: 5 minutes of supine recordings followed by 5 minutes of passive 
head-up tilt to >60°. The actual recordings were preceded by an introductory head-up 
tilt. The HRV values of the last three minutes of the supine and the upright periods 
were used in the analyses, since the signal of these periods was most stable 
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(Tikkakoski et al., 2013). Continuous radial tonometric blood pressure values were 
recorded during the measurements, and the average systolic and diastolic values of 
the last supine three minutes were used for the definition of MetS. The detailed 
description of the measurement protocol has been previously published (Kangas et 
al., 2013; Koskela et al., 2013). 
For assessing cardiac autonomic tone, HRV analysis from a single channel 
electrocardiogram (ECG) was used. The ECG was recorded by the CircMonR device 
(CircMon; JR Medical Ltd) with 200 Hz sampling rate, and Matlab software 
(MathWorks Inc., Natick, Massachusetts, USA) was used for data analyses. Normal 
R-R intervals were recognized, and if the interval differed more than 20% from the 
previous values, the beat was considered ectopic. The processing of artefacts was 
performed using the cubic spline interpolation method (Peltola, 2012). Since the data 
was collected from short-term recordings, the frequency domain method was applied 
(1996). The following HRV variables were calculated using the Fast Fourier 
transformation: (1) total power, (2) power in the low-frequency (LF) range (0.04-0.15 
Hz), (3) power in the high-frequency (HF) range (0.15-0.40 Hz), and (4) LF:HF ratio. 
The recordings were performed in both supine and upright positions. Breathing 
frequency was captured from the CircMonR data, the focus being on the last three 
minutes of the supine and upright phases of recording. 
 
Laboratory tests 
Blood samples were obtained after ~12 hours of fasting, and plasma total cholesterol, 
HDL-C and low-density lipoprotein cholesterol (LDL-C), triglycerides, glucose, 
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creatinine, and cystatin C were determined using the Cobas Integra 700/800 or 
Cobas 6000 (Roche Diagnostics, Basel, Swizerland), and insulin using 
electrochemiluminescence immunoassay (Cobas e 422, Roche Diagnostics). A 
standard 12-lead electrocardiogram was recorded and Cornell voltage QRS duration 
product was calculated for evaluating left ventricular mass ((ESC), 2007). Insulin 
sensitivity was estimated using the Quantitative insulin sensitivity check index 
(QUICKI) (Katz et al., 2000). Estimated glomerulus filtration rate (eGFR) was 
calculated using the CKD-EPI formula (Inker et al., 2012). 
 
Statistical analyses 
The skewed distributions of total power, LF power, HF power, LF:HF ratio, and 
triglycerides were logarithmically transformed before the statistical analyses. The 
original values of the HRV variables are represented in the figures. The statistical 
analyses were performed separately in men and women. In the comparisons of HRV 
variables and the characteristics between control and MetS groups, the independent 
samples of t-test was used. Pearson chi-square test was applied to compare 
smoking habits (current, previous, never) and the use of female hormones between 
the study groups, while Mann-Whitney U-test was used for the comparisons of 
alcohol intake due to its skewed distribution.  
To assess the influence of different confounding factors on the HRV results, three 
separate models of adjustment were crafted. The results adjusted for 1) age, 
smoking (current smoking amount), alcohol intake, and height; 2) model 1 plus 
HR(Billman, 2013a; Sacha, 2013; Monfredi et al., 2014); 3) model 2 plus breathing 
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frequency (Brown et al., 1993; Billman, 2013b). In the adjusted analyses, analysis of 
covariance (ANCOVA) was used with the above variables as covariates.  
HRV data was captured from all 501 participants. However, some of the additional 
data were missing: Information about alcohol intake was missing from 14, and about 
smoking from 5 subjects. LDL-C value was missing from 4, and ECG from 1 subject. 
QUICKI could not be calculate from 47 participants. Due to technical problems, 
breathing frequency was not obtained from 77 subjects in the supine position, and 
from 76 subjects in the upright position. Altogether 482 (96%) subjects were included 
in the adjusted models 1 and 2, while 407-408 (81%) subjects were included in the 
adjusted model 3. 
All testing was 2-sided, and the results in the table were reported as means and 
standard deviations for normally distributed variables, and medians and lower and 
upper quartiles for variables with skewed distribution. For categorical variables, 
numbers of cases and percentages are shown. P-values < 0.05 were considered 
significant. The statistical analyses were performed using IBM SPSS Statistics 
(software version 24, Armonk, New York, USA). 
   
Results 
Study population 
The characteristics of the study participants are presented in Table 1. The MetS and 
the control groups did not differ in age or in alcohol use (p > 0.1 for all). In women, 
the proportion of previous smokers was higher in the MetS group than in the control 
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group (p=0.047), but the proportions of current smokers were similar in the MetS and 
control groups, in both women and men (p > 0.1). As expected, female and male 
subjects with MetS had higher systolic and diastolic blood pressure, BMI, and waist 
circumference; and higher fasting plasma glucose, total cholesterol, triglycerides, 
LDL-C (p < 0.001 for all), and lower HDL-C and QUICKI (p < 0.001 for all) than the 
control subjects. Creatinine was higher in the W-control group than in the W-MetS 
group (p=0.004), but eGFR did not differ between the W-MetS and the W-control 
groups, or between the M-MetS and the M-control groups (p > 0.1 for both). Both 
women and men with MetS had higher Cornell voltage product in ECG than controls 
(p < 0.05). 
 
HRV in supine and upright positions 
Unadjusted supine analyses: Supine total power (Figure 1A) and HF power (Figure 
1B) of HRV were lower in the MetS groups than in the control groups (p < 0.05 for 
analyses in men and in women). The M-MetS group had lower supine LF power 
(Figure 2A) than the M-control group (p = 0.012), while in women supine LF power 
did not differ between the two groups (p = 0.064). The supine LF:HF ratio (Figure 2B) 
did not differ between the MetS and the control groups (p > 0.1). 
Unadjusted upright analyses: Upright total power (Figure 1A), HF power (Figure 1B), 
and LF power (figure 2A) were all different in the comparisons between the M-MetS 
and the M-control groups, and between the W-MetS and the W-control groups (p < 
0.05 for all). The upright LF:HF ratio (Figure 2B) did not differ between the MetS and 
the control groups (p > 0.1).  
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When the results were adjusted for the confounding factors, the differences between 
the MetS and the control groups were not as clear as in the unadjusted analyses. 
The detailed comparisons with the three models of adjustment with the exact 
p-values are presented in the Figures 1 and 2. The results of model 1, with 
adjustments for age, smoking habits, alcohol intake, and height, paralleled well the 
unadjusted results. In model 2 with additional adjustments for HR, the differences 
between the MetS and the control groups in supine total power and HF power in 
women, and supine LF power in men, were no longer significant.  
In model 3, where the HRV results were also adjusted for breathing frequency, only 
the differences in upright total power (Figure 1A), and upright HF power (Figure 1B), 
between the MetS and the control groups remained statistically significant, and these 
differences were only found in women (p < 0.05 for both). In men, all of the adjusted 
p-values in model 3 were not significant (p ≥ 0.105). 
 
Discussion 
The present study demonstrates sex-dependent characteristics of cardiac autonomic 
tone in MetS using the frequency domain analyses of HRV. In HRV indices, the HF 
component represents cardiac parasympathetic activity (Eckberg, 1997; Cooke et al., 
1999; Xhyheri et al., 2012), while the LF component predominantly reflects 
sympathetic activity, although it contains parasympathetic contributions (Eckberg, 
1997; Xhyheri et al., 2012). The interpretation of LF:HF ratio remains somewhat 
controversial. It has been suggested to represent sympathovagal balance (Task 
Force of the European Society of Cardiology and the North American Society of 
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Pacing and Electrophysiology, 1996; Xhyheri et al., 2012), but this interpretation has 
been criticized, and conclusions should be drawn with caution (Eckberg, 1997; 
Cooke et al., 1999; Billman, 2013b). 
Impaired cardiac autonomic tone is associated with cardiovascular risk (Tsuji et al., 
1996; Schuster et al., 2016; Patel et al., 2017) and mortality (Thayer et al., 2010; 
Wulsin et al., 2015). Several studies have reported changes in the HRV indices in 
MetS (Stuckey et al., 2014), and disturbances in autonomic nervous tone have been 
suggested as an important link between MetS and cardiovascular diseases (Grassi, 
2006). However, although the HRV indices are known to be affected by multiple 
factors, aspects like HR, sex, and breathing frequency have been somewhat 
neglected in many reports evaluating the association between MetS and HRV 
(Stuckey et al., 2014). In the current study we found that MetS was associated with 
lower total power, HF power, and LF power of HRV in both women and men. These 
findings are in accordance with previous studies. When the results were adjusted for 
age, smoking habits, alcohol intake, height, HR, and breathing frequency, the 
differences between the MetS and the control groups diminished. Even after all 
adjustments, the total power and HF power, measured in the upright position, were 
still lower in women with MetS than in control women. Similar results were not found 
in men. 
HR has a significant influence on HRV. Higher HRV represents higher 
parasympathetic nervous system activity, which leads to slower HR (Task Force of 
the European Society of Cardiology and the North American Society of Pacing and 
Electrophysiology, 1996). Thus, there is a physiological association between HR and 
HRV indices. In addition, a nonlinear relationship exists between the heart period 
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(RR interval) and HR, causing a mathematical dependence between HRV and HR 
(Sacha & Pluta, 2008; Sacha, 2014). Furthermore, the impact of HR on the 
prognostic value of HRV has been found to differ between sexes: as the HRV indices 
became more dependent on HR, the predictive power of spectral indices increased 
for cardiac death in men, whereas the prognostic power of the indices decreased in 
women (Sacha et al., 2014). Monfredi et al. have concluded that HRV is primarily 
dependent on HR and it cannot be used in any simple way to assess autonomic 
nerve activity to the heart (Monfredi et al., 2014). Therefore, all studies concerning 
HRV should carefully correct for differences in HR before drawing conclusions 
(Monfredi et al., 2014). In comparisons between sexes, women have presented with 
greater vagal activity as indexed by the HF power, but higher HR is also 
characteristic for women (Koenig et al., 2016). Therefore, the relationship between 
the HRV indices and HR is not straightforward. In the present study, HR was taken 
into account in the adjusting process, and this clearly influenced the results. 
Breathing frequency is another important factor that influences the HRV indices 
(Stolarz et al., 2003; Billman, 2011). HRV increases when respiratory frequency 
decreases, while HRV decreases when the tidal volume of ventilation decreases 
(Brown et al., 1993). Furthermore, mechanical factors that occur during respiration 
(stretch of the atria that results from changes in thoracic pressure and cardiac filling) 
influence HRV independent of changes in cardiac autonomic nerve activity (Billman, 
2013b). Several studies have shown that slow, paced breathing strengthens vagal 
activity and modifies HRV (Howorka et al., 2013; Prinsloo et al., 2013; Kromenacker 
et al., 2018; Li et al., 2018). In the current study, the influence of breathing on the 
HRV indices was taken into account by adjusting the results for breathing frequency. 
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The underlying pathophysiology for the association of MetS with impaired HRV is not 
clear, but some factors have been suggested. Insulin resistance is commonly found 
in MetS, and several studies have revealed an association of insulin resistance with 
impaired HRV (Rodriguez-Colon et al., 2010; Hillebrand et al., 2015; Saito et al., 
2015). However, a study that examined HRV in subjects with and without MetS and 
comprised 220 subjects, found that insulin resistance was associated with HR, but 
not with HRV (Stuckey et al., 2015). Inflammatory markers, like interleukin-6 have 
been shown to inversely associate with HRV (Brunner et al., 2002; Haensel et al., 
2008). Also increased plasma leptin level seems to associate with a shift of the 
sympathovagal balance toward sympathetic predominance (Paolisso et al., 2000), 
and this relationship was found to be stronger in women than in men (Flanagan et al., 
2007). Both interleukin-6 and leptin are associated with obesity, and influence in the 
pathogenesis of MetS (Kaur, 2014). When the influence of the different MetS 
components (waist circumference, HDL-C, triglycerides, fasting glucose, and blood 
pressure) on HRV were evaluated in a large cohort of men, all components had a 
strong, linear association (Hemingway et al., 2005), but the strongest association 
was found between HRV and waist circumference (Hemingway et al., 2005; Stuckey 
et al., 2015). However, a study with 2441 participants emphasized the role of 
glycemic status above all other components of MetS as a cause for the impaired 
HRV (Jarczok et al., 2013). 
In the current study the association of MetS with reduced HRV indices was found to 
be stronger in women than in men. This is in good concordance with previous studies 
(Stuckey et al., 2014; Stuckey et al., 2015). The tilt test challenges the autonomic 
nervous system (Avolio & Parati, 2011; Teodorovich & Swissa, 2016), thus it is 
logical that the differences between MetS and control groups found in women were 
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accentuated in the upright position. The reason why women with MetS seem to have 
relatively more disturbances in HRV than men with MetS, remains unknown. 
However, hormonal factors may play an important role in this process.   
Our study has some limitations. 1) The observational design does not allow 
conclusions about causal relationship. 2) The collection of the breathing frequency 
data was not complete from all participants, and the depth of respiration was not 
measured. 3) The information about the hormonal status like menstrual cycle and 
testosterone level could have given additional information, as hormonal factors 
potentially influence HRV. However, the use of exogenous female hormones was 
reported, and no difference was found between the W-MetS and W-control groups. 
4) Subjects using medications that are known to influence HRV were excluded, but it 
remains uncertain whether the medications that were used by some of the 
participants had an effect on the results. 5) The criteria by Alberti et al.(Alberti et al., 
2009) were used for the definition of MetS, instead of the definition by National 
Cholesterol Education Program (NCEP, 2001). Using the criteria of Alberti et al., 
healthier subjects are defined as MetS patients. Of note, despite this MetS definition 
used in the current study, the results showed impaired HRV in women with MetS. 
In conclusion, when the confounding factors were taken into account, the MetS-
related changes in HRV seemed to be more pronounced in women than in men, 
especially in the upright position. It is possible that changes in cardiac autonomic 
tone, presented as lower total power and lower HF power of HRV, may contribute to 
the previously reported greater relative increase in cardiovascular risk in women than 
in men with MetS (Hunt et al., 2004; Iglseder et al., 2005; Schillaci et al., 2006). 
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Figure 1. Box plots of total power (A) and high frequency (HF) power (B) of heart 
rate variability in the study groups (median [line inside box], 25th to 75th percentile 
[box], and range [whiskers]; outliers were excluded from the figure, but were included 
in the statistics). Supine and upright P values in unadjusted analyses and in analyses 
adjusted for 1) age, smoking (current smoking amount), alcohol intake, and height; 
2) model 1 plus heart rate; 3) model 2 plus breathing frequency. Numbers of subjects 
in the groups of men without metabolic syndrome (MetS), men with MetS, women 
without MetS, and women with MetS, respectively: unadjusted n=131, n=121, n=191, 
and n=58; adjusted models 1 and 2 n=125, n=120, n=180, and n=57; adjusted 
model 3 n=110, n=90; n=160, and n=47-48. 
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Figure 2. Box plots of low frequency (LF) power (A) and LF:HF ratio (B) in the study 
groups (median [line inside box], 25th to 75th percentile [box], and range [whiskers]; 
outliers were excluded from the figure, but were included in the statistics). Supine 
and upright P values in unadjusted analyses and in analyses adjusted for 1) age, 
smoking (current smoking amount), alcohol intake, and height; 2) model 1 plus heart 
rate; 3) model 2 plus breathing frequency. Numbers of subjects in the unadjusted and 
adjusted models as in Figure 1. 
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Table 1. Clinical and metabolic characteristics in the study groups. 
Variable M-control M-MetS P-value W-control W-MetS P-value 
Number of subjects 131 121  191 58  
Age (years) 48 ± 10 49 ± 9 0.457 47 ± 9 49 ± 10 0.113 
BMI (kg/m2) 26 ± 3 30 ± 4
 
< 0.001 25 ± 4 30 ± 5
 
< 0.001 
Waist circumference (cm) 95 ± 10 106 ± 8 < 0.001 85 ± 12 98 ± 14
 
< 0.001 
Systolic blood pressure (mmHg) 130 ± 16 144 ± 15 < 0.001 125 ± 18 142 ± 19 < 0.001 
Diastolic blood pressure (mmHg) 75 ± 11 84 ± 10 < 0.001 72 ± 12 81 ± 13 < 0.001 
Smoking status       
Never smoked (n / %) 70 / 53% 57 / 47% 0.316 118 / 62% 28 / 48% 0.067 
Current smoker (n / %) 21 / 16% 18 / 15% 0.800 26 / 14% 8 / 14% 0.972 
Previous smoker (n / %) 40 / 31% 46 / 38% 0.211 47 / 25% 22 / 38% 0.047 
Alcohol intake (standard doses/week) 4 (1-9) 4 (2-11) 0.410 2 (0-3) 2 (0-4) 0.697 
Creatinine (µmol/l) 82 ± 12 82 ± 11 0.551 66 ± 9 62 ± 9 0.004 
eGFR (ml/min/1.73 m2) 95 ± 13 96 ± 13 0.842 95 ± 13 98 ± 13 0.122 
Fasting plasma glucose (mmol/l) 5.4 ± 0.4 5.9 ± 0.5 < 0.001 5,2 ± 0.4 5.8 ± 0.5 < 0.001 
Total cholesterol (mmol/l) 5.2 ± 0.9 5.6 ± 1.1 < 0.001 5,1 ± 1.0 5.6 ± 0.9 < 0.001 
Triglycerides (mmol/l) 1.0 (0.7 - 1.4) 1.7 (1.1 - 2.3) < 0.001 0.9 (0.6 - 1.2) 1.5 (1.0 - 2.0) < 0.001 
High-density lipoprotein cholesterol (mmol/l) 1.5 ± 0.3 1.2 ± 0.3 < 0.001 1.9 ± 0.4 1.5 ± 0.4 < 0.001 
Low-density lipoprotein cholesterol (mmol/l) 3.2 ± 0.9 3.7 ± 1.0 < 0.001 2.8 ± 0.9 3.4 ± 0.8 < 0.001 
Quantitative insulin sensitivity check index 0.365 ± 0.046 0.343 ± 0.042 < 0.001 0.372 ± 0.042 0.339 ± 0.032 < 0.001 
Cornell voltage product in ECG (ms*mm) 1624 ± 823 1807 ± 584* 0.044 1543 ± 523 1739 ± 506* 0.012 
Values are means ± SD except the values for smoking, which are the number of cases and percentages, and the values for triglycerides and 
alcohol intake, which are shown as medians (lower and upper quartiles) due to skewed distribution. M-control, men without MetS; M-MetS, men 
with MetS; W-control, women without MetS; W-MetS, women with MetS; BMI, body mass index; eGFR, estimated glomerulus filtration rate 
(Inker et al., 2012). 
